Starling Oncology, Inc. Interest Expense
Starling Oncology, Inc. (STLN) reported Interest Expense of $61.00 thousand for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2022-08-09
- Starling Oncology, Inc. interest expense for the quarter ending 2022-06-30 was $61.00K, a 24.69% decline year-over-year.
- Starling Oncology, Inc. interest expense for the quarter ending 2022-03-31 was $74.00K, a 26.73% decline year-over-year.
- Starling Oncology, Inc. interest expense for the quarter ending 2021-06-30 was $81.00K.
- Starling Oncology, Inc. interest expense for the quarter ending 2021-03-31 was $101.00K.
- Starling Oncology, Inc. interest expense for fiscal 2021 was $320.00K, a 7.78% decline from fiscal 2020.
- Starling Oncology, Inc. interest expense for fiscal 2020 was $347.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 12 month |
|---|---|---|---|
| 2022-06-30 | $61.00K 10-Q · filed 2022-08-09 | $135.00K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $74.00K 10-Q · filed 2022-05-10 | ||
| 2021-12-31 | $320.00K 10-K · filed 2022-03-11 | ||
| 2021-06-30 | $81.00K 10-Q · filed 2022-08-09 | $182.00K 10-Q · filed 2022-08-09 | |
| 2021-03-31 | $101.00K 10-Q · filed 2022-05-10 | ||
| 2020-12-31 | $347.00K 10-K · filed 2022-03-11 |